Breaking News

First child to receive CAR-T ready for new identity; EQRx abandons business plan around drug pricing

May 9, 2023
From left to right: STAT senior writer Matt Herper, Emily Whitehead, and her father, Tom Whitehead.
Sarah Gonzalez for STAT

STAT+ | Now 18, the first child to ever receive CAR-T cancer therapy is ready for a new identity

After a decade as a symbol for the power of innovative medicines, childhood cancer survivor Emily Whitehead is ready for what's next.

By Jason Mast


STAT+ | EQRx abandons business plan around drug pricing, cuts jobs and programs

The company will focus on only one of several medicines it is developing and on finding new drugs it can acquire.

By Matthew Herper


An MRI helmet out of 'Back to the Future' wins STAT Summit research pick

STAT Madness teams presented their scientific research at the 2023 #STATBreakthrough Summit in San Francisco.

By Theresa Gaffney



Adobe

STAT+ | NIH grant recipients often fail to disclose agency support in patent applications

Lack of patent information may obscure the crucial role the NIH plays in discovering or developing new medicines.

By Ed Silverman


More around STAT
Check out more exclusive coverage with a STAT+ subscription
Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.

Enjoying Cancer Briefing? Tell us about your experience
Continue reading the latest health & science news with the STAT app
Download on the App Store or get it on Google Play
STAT
STAT, 1 Exchange Place, Boston, MA
©2023, All Rights Reserved.

No comments